Recordati

Showing 3 posts of 3 posts found.

astrazeneca_logo_building

AstraZeneca sells off rights to beta-blocker for $300 million

May 22, 2017
Sales and Marketing AstraZeneca, Recordati, Seloken

AstraZeneca announced that it had sold the European rights to its drug, Seloken (metoprolol), to Italian pharmaceutical company Recordati. The …

Lundbeck sells $100m portfolio

January 22, 2013
Sales and Marketing Lundbeck, OTC, Panhematin, Recordati

Italian pharma group Recordati has paid $80 million to Lundbeck for a portfolio of products primarily aimed at the US …

Kowa launches new statin in the UK

August 20, 2010
Sales and Marketing Kowa, Recordati, cv, statin

A new statin has been launched in the UK by Japanese pharma company Kowa.Livazo (pitavastatin) has been approved by the …

The Gateway to Local Adoption Series

Latest content